Synopsis: ICICI Securities, a leading Indian financial services firm, has identified two high-conviction stocks with strong upside potential. Let’s explore which offers a more compelling opportunity for growth after the Q4 results: ICICI Prudential Life Insurance Company or ICICI Lombard General Insurance Company, according to ICICI Securities.
ICICI Securities, a leading Indian financial services company, recently highlighted two high-conviction stocks, offering ratings that suggest significant potential upside. In this article, let’s delve into which of the two, ICICI Prudential Life Insurance Company or ICICI Lombard General Insurance Company, is poised to deliver the highest growth potential, according to ICICI Securities, after Q4 Results.
ICICI Prudential Life Insurance Company Ltd. is one of the leading Indian private insurers, a joint venture between ICICI Bank Ltd. and the UK’s Prudential Corporation Holdings, offering life insurance, savings, and retirement products through diverse channels like agents, banks, and online platforms, known for customer-centricity, strong digital presence, and significant market share.
With a market capitalisation of Rs. 79,719.14 crores on the day’s trade, the shares of ICICI Prudential Life Insurance Company Ltd rose upto 0.7 percent, reaching a high of Rs. 553.85 per share compared to its previous closing price of Rs. 549.95 per share.
The stock is in focus after one of the leading indian brokerage firm, ICICI Securities, initiated a revised Buy Target of Rs. 705 (vs. Rs. 800) on it with an upto 28.1 percent Upside Potential from the previous day’s close.
The company’s revenue declined by 80 percent from Rs. 15,687 crores in March 2024 to Rs. 3,185 crores in March 2025. Meanwhile, Net profit rose from Rs. 385 crores to Rs. 624 crores during the same period.
IPRU achieved a 10.9% YoY growth in Value of New Business (VNB) and expanded its VNB margin to 24.7% in FY26, driven by a better product mix (increased protection sales), cost efficiency, and a favourable yield curve. This shows strong profitability even amid challenging conditions.
The company’s low P/EV ratio (1.5x FY26A, 1.3x FY27E), combined with a robust projected ROEV of 13.7% for FY27/28, indicates attractive valuation and consistent returns, making it a compelling buy opportunity at current levels.
IPRU’s diverse distribution network (agency, bancassurance, partnerships, direct) mitigates channel-specific risks, with strong performance in its partnership and group businesses. This strategic diversification ensures steady growth despite market volatility.
The company has managed costs effectively, with a marginal increase in cost/total premium to 18.2%. This operational efficiency, alongside a strategic focus on high-margin protection products, positions IPRU well for sustained profitability.
With an EV of INR 529.9bn in FY26 and a projected growth trajectory, IPRU’s strong embedded value demonstrates its ability to generate consistent long-term returns. The reduced sensitivity to interest rates and market fluctuations further enhances its stability and long-term growth prospects.
ICICI Lombard General Insurance Company Ltd. is India’s largest private-sector non-life insurer, offering a broad portfolio including motor, health, travel, and business insurance, known for its strong distribution, customer focus, and backed by ICICI Bank as a promoter. Established in 2001 as a joint venture, it’s a major player in the Indian insurance market, providing digital and agent-based solutions for comprehensive protection.
With a market capitalisation of Rs. 91,465.38 crores on the day’s trade, the shares of ICICI Lombard General Insurance Company declined upto 0.8 percent, reaching a low of Rs. 1827.00 per share compared to its previous closing price of Rs. 1841.80 per share.
The stock is in focus after one of the leading indian brokerage firm, ICICI Securities, initiated a Buy Target of Rs. 2250 on it with an upto 22.1 percent Upside Potential from the previous day’s close.
The company’s revenue rose by 12.78 percent from Rs. 6,051 crores in March 2024 to Rs. 6,825 crores in March 2025. Meanwhile, Net profit rose from Rs. 510 crores to Rs. 547 crores during the same period.
ICICIGI has delivered a healthy earnings CAGR of 17%/15% over the last 3/6 years, demonstrating strong compounding potential. Despite sectoral challenges like lower motor growth and higher loss ratios, growth has improved, especially with strong growth in motor and retail health segments. This positions the company for continued earnings growth.
The company has made significant progress in improving its loss ratios, particularly in the motor and health segments. The motor OD loss ratio improved to 67.5% in FY26, and motor TP also showed improvement, reflecting better underwriting and claims management. This sets a strong foundation for further profitability.
Retail health has shown impressive growth (54% YoY in FY26), with improving loss ratios. This is complemented by increased market share and robust investment leverage (3.6x in FY27), driving strong earnings growth potential. ICICIGI’s ability to capitalise on the growing health insurance market gives it a competitive edge.
Positive Underwriting Outlook and Investment Returns
The underwriting outlook for ICICIGI remains positive, with a forecasted combined ratio improvement to 102.5% in FY27. Additionally, the company’s investment returns are solid, with an estimated investment yield of 8.3% in FY27-28, supporting sustained profitability and earnings growth. This also reflects a strong solvency ratio of 2.67x as of March 2026.
ICICIGI’s attractive valuation (P/BV 5.6x in FY26) and projected ROE of 17.4%/18.1% in FY27/28 highlight its potential for solid returns. With a target price of INR 2,250 based on 30x FY28E EPS, the stock is well-positioned to deliver strong returns for investors, particularly in light of the ongoing sectoral tailwinds.
